Filter News
Area of Research
- (-) Isotopes (7)
- (-) Neutron Science (14)
- Advanced Manufacturing (2)
- Biology and Environment (14)
- Clean Energy (42)
- Computational Engineering (1)
- Computer Science (4)
- Fusion and Fission (2)
- Isotope Development and Production (1)
- Materials (34)
- Materials for Computing (5)
- National Security (12)
- Nuclear Science and Technology (4)
- Quantum information Science (1)
- Supercomputing (40)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (5)
- (-) Composites (1)
- (-) Computer Science (6)
- (-) Energy Storage (2)
- (-) Isotopes (6)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (3)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Climate Change (2)
- Coronavirus (5)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (4)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (7)
- Materials Science (13)
- Microscopy (1)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (40)
- Nuclear Energy (2)
- Physics (7)
- Quantum Science (4)
- Security (1)
- Summit (4)
- Sustainable Energy (2)
- Transportation (2)
Media Contacts
![ytterbium](/sites/default/files/styles/list_page_thumbnail/public/2023-05/Ytterbium-176%20approved%20crop_0.jpg?h=1f8bb2ae&itok=lTsZ7UjW)
ORNL’s electromagnetic isotope separator, or EMIS, made history in 2018 when it produced 500 milligrams of the rare isotope ruthenium-96, unavailable anywhere else in the world.
![Jason Gardner, Sandra Davern and Peter Thornton have been elected fellows of AAAS. Credit: Laddy Fields/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2023-02/AAAS_2022%20Thumbnail_0.png?h=b6717701&itok=4TftuioC)
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
![A pure lipid membrane formed using lipid-coated water droplets exhibits long-term potentiation, or LTP, associated with learning and memory, emulating hippocampal LTP observed in the brains of mammals and birds. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-12/22-G03904_Katsaras.png?h=e5aec6c8&itok=reSDZkmx)
While studying how bio-inspired materials might inform the design of next-generation computers, scientists at ORNL achieved a first-of-its-kind result that could have big implications for both edge computing and human health.
![New manufacturing process produces better, cheaper cathodes for lithium-ion batteries. Credit: Andy Sproles/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-12/battery.cathode.illust_1.jpg?h=7b747668&itok=LCfeMjz9)
Researchers at ORNL have developed a new method for producing a key component of lithium-ion batteries. The result is a more affordable battery from a faster, less wasteful process that uses less toxic material.
![ORNL postdoctoral researcher Runming Tao, pictured with a coin cell battery, led an effort to discover new anode materials for fast-charging lithium-ion batteries. Credit: ORNL/Genevieve Martin, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2022-09/2022-P09174.jpg?h=c6980913&itok=C8xoI7J4)
Researchers at ORNL and the University of Tennessee, Knoxville, discovered a key material needed for fast-charging lithium-ion batteries. The commercially relevant approach opens a potential pathway to improve charging speeds for electric vehicles.
![Mars Rover 2020](/sites/default/files/styles/list_page_thumbnail/public/2019-03/Mars_0.jpg?h=c44fcfa1&itok=gSstQOJO)
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
![Ashleigh Kimberlin and Mikayla Molnar achieve success with a gas-trapping apparatus for Ac-225 production. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/Acgastrapping-1.png?h=71976bb4&itok=TbfsnNxp)
In experiment after experiment, the synthetic radioisotope actinium-225 has shown promise for targeting and attacking certain types of cancer cells.
![Spin chains in a quantum system undergo a collective twisting motion as the result of quasiparticles clustering together. Demonstrating this KPZ dynamics concept are pairs of neighboring spins, shown in red, pointing upward in contrast to their peers, in blue, which alternate directions. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/1_full%5B2%5D.png?h=d1cb525d&itok=l8KtOI25)
Using complementary computing calculations and neutron scattering techniques, researchers from the Department of Energy’s Oak Ridge and Lawrence Berkeley national laboratories and the University of California, Berkeley, discovered the existence of an elusive type of spin dynamics in a quantum mechanical system.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.